We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$196M
AUM Growth
+$53.4M
Cap. Flow
-$20.6M
Cap. Flow %
-10.52%
Top 10 Hldgs %
68.42%
Holding
688
New
375
Increased
38
Reduced
38
Closed
155
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNK icon
251
Cinemark Holdings
CNK
$4.22B
$15K 0.01%
+912
New +$15.2K
KRE icon
252
State Street SPDR S&P Regional Banking ETF
KRE
$4.49B
$14.9K 0.01%
365
-246
-40% -$10.1K
FOUR icon
253
Shift4
FOUR
$4.26B
$14.3K 0.01%
+211
New +$13.8K
LNTH icon
254
Lantheus
LNTH
$6.58B
$14.3K 0.01%
+170
New +$15.3K
SEDG icon
255
SolarEdge
SEDG
$2.54B
$14.3K 0.01%
+53
New +$15.2K
XIFR
256
XPLR Infrastructure LP
XIFR
$1.12B
$14K 0.01%
+238
New +$14.3K
DBX icon
257
Dropbox
DBX
$7.49B
$13.8K 0.01%
+517
New +$11.8K
EOI
258
Eaton Vance Enhanced Equity Income Fund
EOI
$805M
$13.7K 0.01%
833
-11,418
-93% -$179K
ENPH icon
259
Enphase Energy
ENPH
$4.94B
$13.4K 0.01%
80
+79
+7,900% +$14.1K
JAZZ icon
260
Jazz Pharmaceuticals
JAZZ
$16.2B
$13.4K 0.01%
+108
New +$14.5K
ALNY icon
261
Alnylam Pharmaceuticals
ALNY
$27.4B
$13.3K 0.01%
+70
New +$13.9K
PTCT icon
262
PTC Therapeutics
PTCT
$6.26B
$13.2K 0.01%
+324
New +$15.9K
HIO
263
Western Asset High Income Opportunity Fund
HIO
$334M
$13.1K 0.01%
+3,457
New +$13.1K
CERE
264
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$13.1K 0.01%
+411
New +$12.6K
CALY
265
Callaway Golf Company
CALY
$3.33B
$13K 0.01%
+654
New +$13.1K
NMAI icon
266
Nuveen Multi-Asset Income Fund
NMAI
$461M
$12.8K 0.01%
1,094
-14,087
-93% -$163K
SNAP icon
267
Snap
SNAP
$7.89B
$12.7K 0.01%
+1,069
New +$10.7K
FAX
268
abrdn Asia-Pacific Income Fund
FAX
$597M
$12.1K 0.01%
746
+413
+124% +$6.7K
PRGS icon
269
Progress Software
PRGS
$1.65B
$12.1K 0.01%
+208
New +$11.8K
PSN icon
270
Parsons
PSN
$4.61B
$12.1K 0.01%
+251
New +$11.4K
SMTC icon
271
Semtech
SMTC
$10.7B
$11.9K 0.01%
+467
New +$10.1K
BBIO icon
272
BridgeBio Pharma
BBIO
$16.1B
$11.7K 0.01%
+678
New +$10.2K
BYNO
273
DELISTED
byNordic Acquisition Corporation Class A Common Stock
BYNO
$11.6K 0.01%
1,100
VIAV icon
274
Viavi Solutions
VIAV
$8.65B
$11.4K 0.01%
+1,004
New +$9.82K
ZD icon
275
Ziff Davis
ZD
$1.94B
$11.3K 0.01%
+161
New +$11K

Similar funds

Elequin Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Elequin Capital held 688 positions worth $196M, up 38% from $142M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Elequin Capital withdrew a net $20.6M in Q2 2023, closing 155 positions and reducing 38 holdings. Its most notable exit was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B, an estimated $6.37M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, up from 0% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Elequin Capital opened a new position in Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock worth $14.5M.

  • Elequin Capital's largest Q2 2023 buy was Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock: 63,711 shares worth $14.5M.
  • Elequin Capital added most to Liberty All-Star Equity Fund in Q2 2023, an estimated $316K increase.
  • Elequin Capital's biggest Q2 2023 reduction was iShares Silver Trust, cutting an estimated $798K.
  • Elequin Capital fully exited Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $6.37M.
  • Elequin Capital's ten largest holdings make up 68% of its $196M portfolio in Q2 2023.
  • Elequin Capital opened 375 new positions and closed 155 in Q2 2023.
  • Elequin Capital's portfolio value rose 38% quarter-over-quarter to $196M.

Based on Elequin Capital's 13F filing for Q2 2023, filed 14 Aug 2023.